Itradue 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. It is indicated for the management of systemic and superficial mycoses, including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and candidiasis. Itradue 100 Capsule is administered orally and exhibits good bioavailability when taken with food, enhancing its absorption. The drug undergoes extensive hepatic metabolism primarily via the cytochrome P450 3A4 enzyme system, necessitating caution when co-administered with other medications metabolized by this pathway to avoid potential drug interactions. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and dizziness. Hepatotoxicity and congestive heart failure are rare but serious side effects requiring prompt medical attention. Itradue 100 Capsule should be used under medical supervision, with dosage adjustments based on the severity of infection and patient response. It is contraindicated in patients with known hypersensitivity to itraconazole or other azole antifungals. Regular monitoring of liver function tests is recommended during prolonged therapy.

Dosage & How to Use